Skip to content
Ferring Pharmaceuticals
  • Twitter
  • Microbial Diversity
  • Dysbiosis and C. Diff Infection
  • C. Diff Infection: An Urgent Threat
  • Recurrent C. Diff Infection Burden
  • Standard of Care and Predominant Risk Factor
  • Limitations of Current Therapeutic Options
  • Resources
  • Learn More
  • References
  • Terms of use
  • Privacy Policy
  • Contact us

C. DIFF INFECTION IS EVEN MORE DANGEROUS WHEN IT RECURS Phase 2

Posted on October 18, 2021 (October 21, 2021) by vakilspremedia

C. diff infection can be more
dangerous when it recurs.

Can the power of the microbiome help
change the course of treatment?

Share this with colleagues!

Share

Posted in For version 2.0

Post navigation

 Get the full story of the microbiome Phase 2
  • Privacy Notice
  • Legal Disclaimer
  • Contact Us

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter “Ferring”) and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only.
©2020 Ferring B.V. US-MBIO-2000006

Footer Logo

 

  • Speaker Program
  • Sign up
  • Site Map
  • PRIVACY POLICY
  • Legal Disclaimer
  • CONTACT US

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter “Ferring”) and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2021 Ferring B.V. US-MBIO-2100090

Ferring Pharmaceuticals logo

 

  • Home
  • The Microbiome Story
  • Resources
  • Discover Ferring
  • Sign up
  • Site Map
  • PRIVACY POLICY
  • Legal Disclaimer
  • CONTACT US
  • REQUEST ADDITIONAL INFORMATION

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter “Ferring”) and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the healthcare community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2021 Ferring B.V. US-MBIO-2100164This site is intended for users in the United States.

  • Home
  • The Microbiome Story
  • Resources
  • Discover Ferring
  • Sign up
  • Site Map
  • PRIVACY POLICY
  • Legal Disclaimer
  • CONTACT US
  • REQUEST ADDITIONAL INFORMATION

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter “Ferring”) and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the healthcare community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2021 Ferring B.V. US-MBIO-2100212This site is intended for users in the United States.

  • C. DIFF Basics
  • Treating C. DIFF
  • C. DIFF MAY COME BACK
  • Stories & support
  • Sign up

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter “Ferring”) and its various products that may be of interest to Ferring’s employees and customers, as well as to members of the healthcare community and the general public. Please feel free to browse this website. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this website, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring. All information on this site is intended for US audiences only. ©2022 Ferring B.V. US-MBIO-2100227

  • JOIN COMMUNITY
Proudly powered by WordPress | Theme: Microbiome US site by understrap.com.(Version: 0.5.6)
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok